Stock · WOCKPHARMA · Healthcare
WOCKPHARMA share price target 2026
Support, resistance, the F&O structure and the BazaarBaazi Crack Score for Wockhardt Limited, refreshed every end-of-day run. A systematic, data-only read on Wockhardt Limited: where it trades versus its 50-day and 200-day lines, the live 52-week range, and momentum, refreshed from the scanner's real price series each run.
The verdict
BazaarBaazi reads WOCKPHARMA as range-bound with a Crack Score of 69/100 as of 21 Jul 2026.
BazaarBaaziSource & method
The scanner's readScanned · scanned 21 Jul 2026
Where WOCKPHARMA stands on the 500-name BazaarBaazi setup scanner: technicals, filed fundamentals and money flow read together, refreshed every run.
Scanned and scored this run, but the evidence is incomplete or conflicted. The engine fails closed to NO_TRADE.
Technical axis
100/100Fundamental axis
0/100Money flow
55/100Result pulse · Q4 FY26
0/100Technical evidence
price above 50DMA
price above 150DMA
price above 200DMA
50 > 150 > 200 DMA (clean stack)
ATR contracting (volatility dry-up)
coiling 1-12% under 52w high
holding above 50DMA
above 200DMA
Red flags
above 200DMA (not a confirmed short-side trend)
weak filed result (score 0.0)
Relative valuation
P/E (TTM)
144.5P/E vs sector
+2.9%Sector percentile
96PEG
n/aScanner levels from the deterministic engine run of 2026-07-21, not a SEBI-registered recommendation and not investment advice. The fundamental axis reads the official filing: Q4 FY26 result.
Price target: support and resistanceComputed 21 Jul 2026
Support and resistance for WOCKPHARMA are read inside the latest show; no spot was printed in the most recent editorial note.
Levels are read inside the latest show. The most recent editorial reference is Systematic Read on 21 Jul 2026.
These are structural reference lines, not a SEBI-registered price target. BazaarBaazi is independent media; the levels frame how the desk reads the WOCKPHARMA chart, refreshed every end-of-day run.
The Crack Score, and how it is built69 / 100 · Constructive
The Crack Score is a deterministic 0 to 100 conviction number. Here is exactly what moved it for WOCKPHARMA, so the figure is a transparent signal rather than a vibe.
Base 50, adjusted by the factors above and clamped to 0 to 100. How the Crack Score works.
The F&O viewHorizon · swing
How the futures and options structure on WOCKPHARMA reads right now.
The editorial price read on WOCKPHARMA is neutral. Strike-level option inventory is unavailable, so the page withholds writer, wall and pin claims. Single-stock F&O on WOCKPHARMA can be thinner than index F&O, so the desk weights price and filed evidence over raw OI. This is not a derivatives trade recommendation.
Why it movedLatest editorial line
The most recent BazaarBaazi read on what is driving WOCKPHARMA.
Systematic read: a disclosed, data-only model on real 1-year price structure.
Read in Systematic Read on 21 Jul 2026. Why WOCKPHARMA moved, the living explainer, tracks every move on one URL.
Latest filed resultsQ4 FY26
Wockhardt Limited's most recent quarter, parsed straight from the official BSE filing. Every figure links back to its primary source.
Result Pulse
0 / 100Revenue
Rs 965 crNet profit
Rs 164 crEPS (quarter)
Rs 10.23| Growth | YoY | QoQ |
|---|---|---|
| Revenue | n/a | n/a |
| Net profit | n/a | n/a |
| Net margin | n/a | |
Figures are the Q4 FY26 result for Wockhardt Limited, parsed straight from the official BSE integrated filing and verified to the paisa. The EPS shown is for the quarter, not a trailing-twelve-month figure, so it is not a P/E input.
Earnings history, every filed quarter32 quarters on record
Wockhardt Limited's official quarterly revenue, EPS and Result Pulse trail, every quarter the desk holds from the verified filings export, back to 30 Jun 2018. These are quarterly facts, not TTM valuation inputs.
WOCKPHARMA official result trail
32 quarters
Quarterly figures only: revenue, net profit and EPS are copied from official filings. EPS here is not trailing twelve month EPS and is not used for valuation.
| Quarter | Revenue | EPS | PAT YoY | Pulse | Source |
|---|---|---|---|---|---|
| Q4 FY26ended 31 Mar 2026 / Consolidated, audited | Rs 965 cr | Rs 10.23 | n/a | n/a | Filing |
| Q3 FY26ended 31 Dec 2025 / Consolidated, audited | Rs 888 cr | Rs 3.61 | n/a | 40/100 | Filing |
| Q2 FY26ended 30 Sep 2025 / Consolidated, audited | Rs 782 cr | Rs 4.81 | n/a | 60/100 | Filing |
| Q1 FY26ended 30 Jun 2025 / Consolidated, audited | Rs 738 cr | Rs -5.53 | n/a | 42/100 | Filing |
| Q4 FY25ended 31 Mar 2025 / Consolidated, audited | Rs 743 cr | Rs -1.57 | n/a | 42/100 | Filing |
| Q3 FY25ended 31 Dec 2024 / Consolidated, audited | Rs 721 cr | Rs 0.91 | n/a | n/a | Filing |
| Q2 FY25ended 30 Sep 2024 / Consolidated, audited | Rs 809 cr | Rs -1.47 | n/a | n/a | Filing |
| Q1 FY25ended 30 Jun 2024 / Consolidated, audited | Rs 739 cr | Rs -0.95 | n/a | n/a | Filing |
| Q4 FY24ended 31 Mar 2024 / Consolidated, audited | Rs 700 cr | Rs -11.64 | n/a | n/a | Filing |
| Q3 FY24ended 31 Dec 2023 / Consolidated, audited | Rs 701 cr | Rs -5.75 | n/a | n/a | Filing |
| Q2 FY24ended 30 Sep 2023 / Consolidated, audited | Rs 753 cr | Rs -5.37 | n/a | n/a | Filing |
| Q1 FY24ended 30 Jun 2023 / Consolidated, audited | Rs 644 cr | Rs -9.28 | n/a | n/a | Filing |
| Q4 FY23ended 31 Mar 2023 / Consolidated, audited | Rs 678 cr | Rs -14.37 | n/a | n/a | Filing |
| Q3 FY23ended 31 Dec 2022 / Consolidated, audited | Rs 699 cr | Rs -6.62 | n/a | n/a | Filing |
| Q2 FY23ended 30 Sep 2022 / Consolidated, audited | Rs 679 cr | Rs -13.15 | n/a | n/a | Filing |
| Q1 FY23ended 30 Jun 2022 / Consolidated, audited | Rs 595 cr | Rs -4.64 | n/a | n/a | Filing |
| Q4 FY22ended 31 Mar 2022 / Consolidated, audited | Rs 655 cr | Rs -21.20 | n/a | n/a | Filing |
| Q3 FY22ended 31 Dec 2021 / Consolidated, audited | Rs 854 cr | Rs -0.61 | n/a | n/a | Filing |
| Q2 FY22ended 30 Sep 2021 / Consolidated, audited | Rs 862 cr | Rs 3.03 | n/a | n/a | Filing |
| Q1 FY22ended 30 Jun 2021 / Consolidated, audited | Rs 860 cr | Rs -1.15 | n/a | n/a | Filing |
| Q4 FY21ended 31 Mar 2021 / Consolidated, audited | Rs 632 cr | Rs -8.38 | n/a | n/a | Filing |
| Q3 FY21ended 31 Dec 2020 / Consolidated, audited | Rs 764 cr | Rs 1.38 | n/a | n/a | Filing |
| Q2 FY21ended 30 Sep 2020 / Consolidated, audited | Rs 714 cr | Rs 0.32 | n/a | n/a | Filing |
| Q1 FY21ended 30 Jun 2020 / Consolidated, audited | Rs 598 cr | Rs 68.64 | n/a | n/a | Filing |
| Q4 FY20ended 31 Mar 2020 / Consolidated, audited | Rs 687 cr | Rs 4.36 | n/a | n/a | Filing |
| Q3 FY20ended 31 Dec 2019 / Consolidated, audited | Rs 869 cr | Rs 0.87 | n/a | n/a | Filing |
| Q2 FY20ended 30 Sep 2019 / Consolidated, audited | Rs 802 cr | Rs -7.42 | n/a | n/a | Filing |
| Q1 FY20ended 30 Jun 2019 / Consolidated, audited | Rs 863 cr | Rs -4.06 | n/a | n/a | Filing |
| Q4 FY19ended 31 Mar 2019 / Consolidated, audited | Rs 979 cr | Rs -1.31 | n/a | n/a | Filing |
| Q3 FY19ended 31 Dec 2018 / Consolidated, audited | Rs 1,046 cr | Rs -6.42 | n/a | n/a | Filing |
| Q2 FY19ended 30 Sep 2018 / Consolidated, audited | Rs 1,126 cr | Rs -2.06 | n/a | n/a | Filing |
| Q1 FY19ended 30 Jun 2018 / Consolidated, audited | Rs 1,008 cr | Rs -7.79 | n/a | n/a | Filing |
The official financialsFiled to 31 Mar 2026
Wockhardt Limited's statements as filed: trailing twelve month P&L, the balance sheet, and the cash engine. Parsed from official XBRL, shown in crore.
Trailing twelve months, on filed quarters
Revenue (TTM)
3,373 crNet profit (TTM)
199 crEBIT (TTM)
451 crProfit before tax (TTM)
238 crNet margin (TTM)
5.9%Finance costs (TTM)
213 crBalance sheet, as filed 2026-03-31
Total assets
8,615 crShareholder equity
5,281 crTotal borrowings
2,125 crCash and equivalents
217 crInventory
887 crTrade receivables
588 crThe cash engine, latest filed year
Operating cash flow
390 crCapex
136 crFree cash flow
254 crInvesting flow
241 crFinancing flow
54.0 crAnnual trail, filed year over filed year
| Year | Revenue | Net profit | Equity | Borrowings | CFO |
|---|---|---|---|---|---|
| FY26 | 3,373 cr | 199 cr | 5,281 cr | 2,125 cr | 390 cr |
| FY25 | 3,012 cr | -57.0 cr | 4,657 cr | 1,859 cr | -22.0 cr |
| FY24 | 2,798 cr | -472 cr | 3,662 cr | 2,112 cr | 219 cr |
| FY23 | 2,651 cr | -621 cr | 3,662 cr | 1,887 cr | 153 cr |
| FY22 | 3,230 cr | -279 cr | 4,202 cr | 1,862 cr | 413 cr |
| FY21 | 2,708 cr | 689 cr | 3,760 cr | 1,569 cr | n/a |
Every figure is parsed from Wockhardt Limited's official NSE XBRL filings by the BazaarBaazi earnings lab and shown in crore rupees. Display data, not a valuation model input.
Management on record3 earnings calls
Every WOCKPHARMA earnings call BazaarBaazi has indexed, latest 30 Jun 2026. Read management in its own words, straight from the filed transcript.
Wockhardt Limited earnings calls on record
3 calls since 28 Feb 2023
Each entry links to the transcript PDF the company filed with the exchange. Primary sources, in management's own words.
What changed1 disclosure
Every recent official filing from Wockhardt Limited, straight from the exchange feed, with the BazaarBaazi Event Heat on the disclosure flow.
Wockhardt Limited's most recent official filing is a Earnings dated 31 Mar 2026.
Event Heat
61 / 100Event Heat is a dated net read of Wockhardt Limited's last 180 days of official disclosures, balancing the constructive filings against the ones to watch. It is a signal from what the company has filed, not investment advice. Every line above links to its official exchange filing, and the full market desk is at the disclosures hub.
Key fundamentalsEditorial reference
The anchor data BazaarBaazi references when reading the WOCKPHARMA chart. Not a substitute for a registered research note.
| Ticker | WOCKPHARMA |
|---|---|
| Full name | Wockhardt Limited |
| Sector | Healthcare |
| Index class | MID CAP |
| ISIN | INE049B01025 |
| Market-cap band | ~30,400 cr (indicative) |
| Last referenced level | Inside latest show |
| Last session move | Not referenced this cycle |
| Editorial line in | Systematic Read on 21 Jul 2026 |
| Aliases tracked | WOCKPHARMA |
Reference chartLevels in show
The daily frame the desk reads on WOCKPHARMA.
FAQ11 reader questions · AEO-eligible
The line on WOCKPHARMA, distilled and schema-marked for AI Overview, Perplexity, and reader search.
What is the WOCKPHARMA share price target for 2026?
BazaarBaazi does not publish a SEBI-registered price target on WOCKPHARMA. The desk reads structural support and resistance inside each show against the printed spot; the most recent editorial line is Systematic Read on 21 Jul 2026.
What is BazaarBaazi's Crack Score for WOCKPHARMA?
The BazaarBaazi Crack Score for WOCKPHARMA is 69 out of 100 as of 21 Jul 2026, a constructive reading. It is a computed conviction number from the signed stance, how consistent the recent verdicts have been, the quality of the printed structure, and how fresh the review is. It is a transparency signal, not investment advice.
What is the F&O view on WOCKPHARMA?
Strike-level option inventory for WOCKPHARMA is unavailable, so BazaarBaazi withholds participant, direction and positioning claims. The editorial chart stance is not substituted for an option-chain observation.
What sector is WOCKPHARMA in and which peers does BazaarBaazi track?
WOCKPHARMA sits in Healthcare (mid cap), indicative market cap ~30,400 cr (indicative), ISIN INE049B01025. The peers BazaarBaazi reads alongside it are GLAND PHARMA LIMITED, Eris Lifesciences Limited, ACUTAAS CHEMICALS LIMITED. A systematic, data-only read on Wockhardt Limited: where it trades versus its 50-day and 200-day lines, the live 52-week range, and momentum, refreshed from the scanner's real price series each run.
How often is the WOCKPHARMA view updated?
This page is one evergreen URL refreshed in place. The Crack Score and levels re-compute on every BazaarBaazi end-of-day run, and the dated stamp shows the last refresh. The latest signed verdict on WOCKPHARMA is neutral, published in Systematic Read on 21 Jul 2026.
Is WOCKPHARMA a qualifying setup on the BazaarBaazi scanner right now?
On the 2026-07-21 run of the 500-name BazaarBaazi setup scanner, Wockhardt Limited sits in the Scanned tier with a setup score of 61/100 (technical 100, fundamental 0). The scanner is a deterministic engine over real OHLCV and official filings, refreshed nightly, and it is a signal rather than investment advice.
Where can I read Wockhardt Limited's earnings call transcripts?
BazaarBaazi indexes 3 WOCKPHARMA earnings calls going back to 2023-02-28, latest 2026-06-30. Every entry on this page links straight to the transcript PDF the company filed with the exchange, so you read management in the primary source.
What was Wockhardt Limited's Q4 FY26 net profit?
Wockhardt Limited reported a net profit of Rs 164 cr for Q4 FY26 (the quarter ended 31 March 2026). The figure is from the company's official NSE filing.
What was Wockhardt Limited's Q4 FY26 revenue?
Wockhardt Limited reported revenue of Rs 965 cr for Q4 FY26. The figure is from the company's official NSE filing.
How does BazaarBaazi rate Wockhardt Limited's Q4 FY26 result?
BazaarBaazi gives Wockhardt Limited's Q4 FY26 result a Result Pulse of 0 out of 100, with a verdict of Insufficient data. The Result Pulse is a BazaarBaazi editorial score for the quality of the filed result, not investment advice.
What has Wockhardt Ltd announced recently?
The most recent official filing on record for Wockhardt Ltd is an earnings dated 31 Mar 2026. It is the company's own earnings disclosure to the exchange, and it links to that filing on the BazaarBaazi stock page rather than to any third-party summary.
Related stock views
The names BazaarBaazi reads alongside WOCKPHARMA, each a living view refreshed every end-of-day run.